|
2022
|
Invention
|
Biomarker for tuberous sclerosis complex with no mutation identified in tsc1 or tsc2 gene, and us... |
|
|
Invention
|
Biomarker for tuberous sclerosis complex-no mutation identified and use thereof. Disclosed are a ... |
|
2021
|
Invention
|
Method of reducing artefact variants in high throughput-sequencing and uses thereof.
A method of... |
|
|
Invention
|
Method for reducing artificially introduced artefact mutations in high-flux sequencing, and appli... |
|
2020
|
Invention
|
Method and system for identifying target region of digital pathology slide, device, and medium.
... |
|
|
Invention
|
Method, system and device for identifying target area of digital pathology slide, and medium. A m... |
|
|
Invention
|
Tumor cell content evaluation method, system and computer device.
Embodiments of this applicatio... |
|
|
Invention
|
Tumor cell content evaluation method and system, and computer device and storage medium. A tumor ... |
|
|
Invention
|
Method for detecting uniparental disomy based upon ngs-trio, and use thereof.
A method for detec... |
|
|
Invention
|
Method for detecting uniparental disomy on basis of ngs-trio and use thereof. A method for detect... |
|
|
Invention
|
Method for screening pathogenic uniparental disomy and use thereof.
A method of screening a path... |
|
|
Invention
|
Method for screening pathogenic uniparental disomy and use thereof. Disclosed are a method for sc... |
|
2019
|
Invention
|
Uses of methylated loci in sonic hedgehog medulloblastoma.
Provided is a use of methylated locus... |
|
|
Invention
|
Use of shh-type medulloblastoma methylation sites. Disclosed in the present invention is a use of... |
|
2011
|
Invention
|
Immunoassays using antibodies specific to carbamazepine. The present disclosure is directed to an... |
|
|
Invention
|
Antibodies specific to carbamazepine. The present disclosure is directed to antibodies specific t... |
